Tbx2 plays a critical role in determining fates of cardiomyocytes. Little is known about the contribution of TBX2 3′ untranslated region (UTR) variants to the risk of congenital heart defect (CHD). Thus, we aimed to determine the association of single-nucleotide polymorphisms (SNPs) in TBX2 3′ UTR with CHD susceptibility.
We recruited 1285 controls and 1241 CHD children from China. SNPs identification and genotyping were detected using Sanger Sequencing and SNaPshot. Stratified analysis was conducted to explore the association between rs59382073 polymorphism and CHD subtypes. Functional analyses were performed by luciferase assays in HEK-293T and H9c2 cells.
Among five TBX2 3′UTR variants identified, rs59382073 minor allele T carriers had a 1.89-fold increased CHD risk compared to GG genotype (95% CI = 1.48–2.46, P = 4.48 × 10−7). The most probable subtypes were right ventricular outflow tract obstruction, conotruncal, and septal defect. G to T variation decreased luciferase activity in cells. This discrepancy was exaggerated by miR-3940 and miR-708, while their corresponding inhibitors eliminated it.
T allele of rs59382073 in TBX2 3′UTR contributed to greater CHD risk in the Han Chinese population. G to T variation created binding sites for miR-3940 and miR-708 to inhibit gene expression.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $64.85 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Triedman, J. K. & Newburger, J. W. Trends in congenital heart disease: the next decade. Circulation 133, 2716–2733 (2016).
Pradat, P. et al. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr. Cardiol. 24, 195–221 (2003).
Zaidi, S. et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498, 220–223 (2013).
Christoffels, V. M. et al. Development of the pacemaker tissues of the heart. Circ. Res. 106, 240–254 (2010).
Cai, C. L. et al. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 132, 2475–2487 (2005).
Ma, L. et al. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132, 5601–5611 (2005).
Sakabe, M. et al. Ectopic retinoic acid signaling affects outflow tract cushion development through suppression of the myocardial Tbx2-Tgfβ2 pathway. Development 139, 385–395 (2012).
Singh, M. K. et al. Tbx20 is essential for cardiac chamber differentiation and repression of Tbx2. Development 132, 2697–2707 (2005).
Habets, P. E. M. H. et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 16, 1234–1246 (2002).
Boogerd, K.-J. et al. Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43. Cardiovasc. Res. 78, 485–493 (2008).
Barron, M. R. et al. Serum response factor, an enriched cardiac mesoderm obligatory factor, is a downstream gene target for Tbx genes. J. Biol. Chem. 280, 11816–11828 (2005).
Harrelson, Z. et al. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131, 5041–5052 (2004).
Wang, F. et al. A TBX5 3’UTR variant increases the risk of congenital heart disease in the Han Chinese population. Cell Discov. 3, 17026 (2017).
Pang, S. et al. Novel and functional sequence variants within the TBX2 gene promoter in ventricular septal defects. Biochimie 95, 1807–1809 (2013).
Houyel, L. et al. Population-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code. Orphanet. J. Rare Dis. 6, 64 (2011).
Botto, L. D. et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res. Part A Clin. Mol. Teratol. 79, 714–727 (2007).
Campbell, C. et al. Cloning and mapping of a human gene (TBX2) sharing a highly conserved protein motif with the Drosophila omb gene. Genomics 28, 255–260 (1995).
Campbell, C. E., Casey, G. & Goodrich, K. Genomic structure of TBX2 indicates conservation with distantly related T-box genes. Mamm. Genome. 9, 70–73 (1998).
Law, D. J. et al. Identification, characterization, and localization to Chromosome 17q21-22 of the human TBX2 homolog, member of a conserved developmental gene family. Mamm. Genome. 6, 793–797 (1995).
Radio, F. C., et al., TBX2 gene duplication associated with complex heart defect and skeletal malformations. Am. J. Med. Genet. A 152A, 2061–2066 (2010).
Yamada, M. et al. Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early heart development: evidence for BMP2 induction of Tbx2. Dev. Biol. 228, 95–105 (2000).
Sizarov, A. et al. Formation of the building plan of the human heart: morphogenesis, growth, and differentiation. Circulation 123, 1125–1135 (2011).
Aanhaanen, W. T. J. et al. The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ. Res. 104, 1267–1274 (2009).
Moorman, A. F. M. et al. The heart-forming fields: one or multiple? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 362, 1257–1265 (2007).
Shirai, M., et al., T-box 2, a mediator of Bmp-Smad signaling, induced hyaluronan synthase 2 and Tgfbeta2 expression and endocardial cushion formation. Proc. Natl Acad. Sci. USA 106, 18604-18609 (2009).
Kiriakidou, M. et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129, 1141–1151 (2007).
Nikolova, E., Jordanov, I. & Vitanov, N. Dynamical analysis of the microRNA – mediated protein translation process. BIOMATH 2, 1210071 (2013).
Pillai, R. S. et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309, 1573–1576 (2005).
Pelletier, C. & Weidhaas, J. B. MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert. Rev. Mol. Diagn. 10, 817–829 (2014).
Liang, D. et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 70, 9765–9776 (2010).
Sabina, S. et al. Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects. J. Mol. Cell. Cardiol. 60, 84–89 (2013).
This work was supported by the National Natural Science Foundation of China (81300126, 81770312) to Feng Wang, and the National Natural Science Foundation of China (81470442) to Yong-hao Gui.